Smith & Nephew Dividends - SN.

Smith & Nephew Dividends - SN.

Buy
Sell
Stock Name Stock Symbol Market Stock Type
Smith & Nephew Plc SN. London Ordinary Share
  Price Change Price Change % Stock Price Last Trade
-10.00 -0.89% 1,108.50 13:25:10
Open Price Low Price High Price Close Price Previous Close
1,117.00 1,103.00 1,118.00 1,118.50
more quote information »
Industry Sector
HEALTH CARE EQUIPMENT & SERVICES

Smith & Nephew SN. Dividends History

Announcement Date Type Currency Dividend Amount Period Start Period End Ex Date Record Date Payment Date Total Dividend Amount
28/07/2022InterimUSX14.431/12/202131/12/202229/09/202230/09/202226/10/20220
22/02/2022FinalUSX23.131/12/202031/12/202131/03/202201/04/202211/05/202237.5
29/07/2021InterimUSX14.431/12/202031/12/202130/09/202101/10/202127/10/20210
18/02/2021FinalUSX23.131/12/201931/12/202001/04/202106/04/202112/05/202137.5
29/07/2020InterimUSX14.431/12/201931/12/202001/10/202002/10/202028/10/20200
20/02/2020FinalUSX23.131/12/201831/12/201902/04/202003/04/202006/05/202037.5
31/07/2019InterimUSX14.431/12/201831/12/201903/10/201904/10/201930/10/20190
07/02/2019FinalUSX2231/12/201731/12/201804/04/201905/04/201908/05/201936
26/07/2018InterimUSX1431/12/201731/12/201804/10/201805/10/201831/10/20180
08/02/2018FinalUSX22.731/12/201631/12/201705/04/201806/04/201809/05/201835
27/07/2017InterimUSX12.331/12/201631/12/201705/10/201706/10/201701/11/20170
09/02/2017FinalUSX18.531/12/201531/12/201630/03/201731/03/201710/05/201730.8
28/07/2016InterimUSX12.331/12/201531/12/201606/10/201607/10/201625/10/20160
04/02/2016FinalUSX1931/12/201431/12/201521/04/201622/04/201611/05/201630.8
30/07/2015InterimUSX11.831/12/201431/12/201508/10/201509/10/201527/10/20150
05/02/2015FinalUSX18.631/12/201331/12/201416/04/201517/04/201506/05/201529.6
01/08/2014InterimUSX1131/12/201331/12/201422/10/201424/10/201411/11/20140
06/02/2014FinalUSX1731/12/201231/12/201320/04/201422/04/201407/05/201427.4
01/08/2013InterimUSX10.431/12/201231/12/201309/10/201311/10/201329/10/20130
07/02/2013FinalUSX16.231/12/201131/12/201217/04/201319/04/201308/05/201326.1
02/08/2012InterimUSX9.931/12/201131/12/201210/10/201212/10/201230/10/20120
02/02/2012FinalUSX10.831/12/201031/12/201118/04/201220/04/201209/05/201217.4
05/08/2011InterimUSX6.631/12/201031/12/201112/10/201114/10/201101/11/20110
10/02/2011FinalUSX9.8231/12/200931/12/201001/05/201103/05/201119/05/201115.82
05/08/2010InterimUSX631/12/200931/12/201013/10/201015/10/201002/11/20100
12/02/2010FinalUSX8.9331/12/200831/12/200921/04/201023/04/201012/05/201014.39
30/07/2009InterimUSX5.4630/12/200830/06/200914/10/200916/10/200903/11/20090
12/02/2009FinalUSX8.1231/12/200731/12/200815/04/200917/04/200908/05/200913.58
07/08/2008InterimUSX4.9628/12/200728/06/200815/10/200817/10/200807/11/20080
07/02/2008FinalUSX7.3831/12/200631/12/200716/04/200818/04/200809/05/200811.89
02/08/2007InterimUSX4.5130/12/200630/06/200717/10/200719/10/200709/11/20070
08/02/2007InterimUSX3.4131/12/200531/12/200618/04/200720/04/200711/05/20070
08/02/2007FinalUSX031/12/200531/12/200601/01/197001/01/197001/01/19705.62
27/07/2006InterimUSX2.2101/01/200601/07/200618/10/200620/10/200610/11/20060
09/02/2006FinalUSX3.531/12/200431/12/200519/04/200621/04/200612/05/20065.6
04/08/2005InterimUSX2.130/12/200430/06/200519/10/200521/10/200511/11/20050
03/02/2005FinalUSX3.231/12/200331/12/200420/04/200522/04/200513/05/20055.1
05/08/2004InterimUSX1.903/01/200403/07/200420/10/200422/10/200412/11/20040
05/02/2004FinalUSX3.131/12/200231/12/200321/04/200423/04/200414/05/20044.95
31/07/2003InterimUSX1.8528/12/200228/06/200313/08/200315/08/200312/09/20030
07/02/2003FinalUSX331/12/200131/12/200220/04/200322/04/200316/05/20034.8
01/08/2002InterimUSX1.830/12/200130/06/200216/10/200218/10/200215/11/20020
07/02/2002FinalUSX2.931/12/200031/12/200117/04/200219/04/200217/05/20024.65
02/08/2001InterimUSX1.7530/12/200030/06/200107/11/200109/11/200105/12/20010
15/02/2001FinalUSX2.831/12/199931/12/200018/04/200120/04/200118/05/20014.5
05/07/2000SpecialUSX37.1431/12/199931/12/200007/08/200004/08/200011/08/20000
08/08/2000InterimUSX1.701/01/200001/07/200006/11/200010/11/200006/12/20000
23/02/2000FinalUSX431/12/199831/12/199902/05/200008/05/200002/06/20006.5
09/08/1999InterimUSX2.503/01/199903/07/199901/11/199905/11/199908/12/19990
25/02/1999FinalUSX3.831/12/199731/12/199804/05/199910/05/199904/06/19996.2
26/02/1998FinalUSX3.831/12/199631/12/199701/06/199805/06/199801/07/19986.2

Top Dividend Posts

Top Posts
Posted at 07/12/2022 15:38 by suetballs
https://www.telegraph.co.uk/news/2022/12/05/faulty-knee-replacements-given-10000-patients/
Glad this wasn't sn.
Suet

Posted at 04/11/2022 17:32 by cerrito
As a SN. holder I listened to most of the recording of yesterday's webcast.
Alot of good stuff especially in logistics and optimization of inventory and US improvement but what stopped me pushing the buy button was not so much the supply shortages(especially semi conductors and resins) but rather that in the Q&A the difficulty they were having on passing on cost increases came up 2/3 times.

Posted at 03/11/2022 10:19 by disc0dave45
Seem to be following the same stocks!From the healthcare sector I've got SN on my watchlist and good to see they are in line. Some of the constraining factors (materials and staff shortages, FX headwinds) could develop into major issues but who knows.
Posted at 28/7/2022 12:47 by essentialinvestor
Surprised that no one commented on the large CEO share dump a few week back -

Those shares granted in lieu of the lapsed options in his previous role on
taking the SN position.

Posted at 28/7/2022 12:44 by essentialinvestor
£13/4 bn to take this out - plus their £2 bn approx in net debt.


Is SN. worth £15 bn...looks a stretch to me but never say never.


Stryker already carry a lump of debt, realistically only leaves JnJ imv.

Posted at 28/7/2022 08:47 by essentialinvestor
Can't see previous FY earnings estimates being achieved as SN
now appear to be guiding lower on margin for the full year ?.

Posted at 28/7/2022 07:22 by roguetraderuk
i have mentioned this margin issue on china before. i was surprised no analysts looked at it over the past few months. hence the "surprise" today. since china implemented zero covid its essentially put sn supply china issues in that zone into a semi permanent state. its quite poss they continue with this for a few years, so you are going to have tough comps on this issue til the end of the year now. so you are having to set back equilibrium towards the end of the year. areas of past support are around 1050 and there is a lt gap at 965. the former is quite poss and i wouldnt rule out the latter if the general mkt softens.
Posted at 15/6/2022 14:47 by pdosullivan
I doubled my holding in this one earlier today. It makes no sense for SN/ to be trading 2% above the COVID trough when electives were cancelled etc.
Posted at 24/4/2022 09:59 by chamer1
With a trading update imminent on Thursday and much to be positive about with this company I think you will be lucky to see the low 12s again, unless the general market is very poor for the first part of the week and SN. tracks it down unavoidably. I think now is time to stay invested and we could see £18 by the end of 2022
Posted at 17/12/2021 14:13 by roguetraderuk
some advice re sn. the share price will begin to outperform when the mkt believes elected surgery for sn. has turned the corner. it will likely go mkt perform as others start giving signals (stryker, medtronic, intuitive etc) but as i say the big outperformance will come when the company points to a return to trend growth. demand issue and supply chains issues all due to covid and the variants are extending the point of turn in trend. i think it should reach equilibrium by q2 2022, i suspect the shares will bottom by then if not sooner. it all depends on the news and if its leaked and other news from others in the area. i dont think they will get too much cheaper as i would expect the americans to start sniffing. there is plenty to put right at sn. but that means a large upside for any buyer. personally i think they will stay independant until jnj do their split and the jnj arm likely picks up sn. but we will see. if they get cheap enough (10 quid or lower) someone may step up earlier. given that they are likely to underperfrom their peers next year, i wouldnt expect outperformance from here now, but of course i cant see the future and a bid would change all that.
Your Recent History
LSE
SN.
Smith & Ne..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20230131 13:40:37